Reuters logo
2 months ago
BRIEF-Lilly says Jardiance tablets to be studied in chronic kidney disease
June 12, 2017 / 12:09 PM / 2 months ago

BRIEF-Lilly says Jardiance tablets to be studied in chronic kidney disease

June 12 (Reuters) - Eli Lilly And Co:

* Jardiance® (empagliflozin) tablets to be studied in chronic kidney disease

* Says plans to conduct a new, large clinical outcomes trial investigating Jardiance along with Boehringer Ingelheim

* Eli Lilly And Co - ‍trial will enroll people with chronic kidney disease both with and without type 2 diabetes​

* Says trial will enroll people with chronic kidney disease both with and without type 2 diabetes

* Eli Lilly - ‍boehringer Ingelheim, co announced plans to conduct new, large clinical outcomes trial investigating Jardiance tablets Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below